Abstract:Endovascular thrombectomy is routinely performed in patients undergoing a large vessel occlusion. This process not only allows for the removal of a blood clot but also for the selective delivery of potential therapeutics directly to the site of injury. The intra‐arterial (IA) route of drug administration in the mouse was developed to bridge the gap between animal stroke treatments and clinical stroke therapy. We have previously shown this delivery method targets the site of injury while blunting systemic effects that have proven problematic with intraperitoneal routes. Here, we adapted the IA method for use in rats, combining it with a clinically relevant large vessel occlusion stroke model (MCAO). Our goal was to characterize variances in the model in order to optimize potential therapeutic delivery methods to the ipsilaterally affected hemisphere. Male and female Sprague‐Dawley rats (4 months of age) were subjected to placement of micro‐angio tubing at the bifurcation of the common carotid artery (CCA), with delivery through the internal carotid artery (ICA). We then determined the optimal infusion rate and volume using injection of India ink and evaluation of vascular distribution within the brain and the liver. Importantly, we found the infusion rate and volume varied depending on sex and body weight. India ink was selectively delivered to the ipsilateral side of the brain in males (370–460 g) at 4 μl/min with a max volume of 25 μl and in females (250–300 g) at 2.5 μl/min with a max volume of 25 μl. Following these guidelines, no ink was observed in the liver of these animals, indicating reduced systemic circulation of administered compounds. We then performed a 5‐hour transient MCAO, on male and female Sprague‐Dawley rats (4 months of age), to mimic human stroke, since 5 hours is the average time from the clinical presentation of stroke to the thrombectomy procedure. A silicone coated monofilament was advanced till resistance was felt, occluding the MCA territory. At the 5 hour time point, we removed the monofilament and inserted the mico‐angio tubing at the same entry point on the bifurcation of the CCA. We performed variant injections using different volumes and rates, measuring delivery of dye (India Ink) and rate of induced subarachnoid hemorrhage. A rate of 4 ul/min with a max volume of 25 ul was optimal in males, and a rate of 2.5 ul/min with a max volume of 25 ul was optimal in females. The results showed that, even with a large vessel occlusion, and removal of the monofilament (recanalization), the IA injection using these sex‐specific rates and volumes resulted in appropriate limited dye delivery without ruptured subarachnoid hemorrhage. This IA method is ideally suited for combination with the MCAO stroke model and mirrors the human patient undergoing an endovascular thrombectomy. This model provides an investigative opportunity to test neuroprotective drugs and other pharmacotherapies. University of Kentucky Center for Advanced Translational Stroke Science, Surgery Core

The Window of Opportunity for Treatment of Focal Cerebral Ischemic Damage with Noninvasive Intranasal Insulin-Like Growth Factor-I in Rats.

Non-Invasive Intranasal Insulin-Like Growth Factor-I Reduces Infarct Volume and Improves Neurologic Function in Rats Following Middle Cerebral Artery Occlusion

Intranasal IGF-1 Protects Against Transient Focal Cerebral Ischemia in Rats Following Middle Cerebral Artery Occlusion (MCAO)

Prospects for the Use of Intranasally Administered Insulin and Insulin-Like Growth Factor-1 in Cerebral Ischemia

Intravenous Administration of Hair Follicle Mesenchymal Stem Cells and Insulin Growth Factor-1 Improves the Neurological Performances of Rats Following Focal Cerebral Ischemia

Intranasal Delivery of Nerve Growth Factor to Protect the Central Nervous System Against Acute Cerebral Infarction.

Combined Postischemic Hypothermia And Delayed Mk-801 Treatment Attenuates Neurobehavioral Deficits Associated With Transient Global-Ischemia In Rats

Effect of Delayed MK-801 (dizocilpine) Treatment with or Without Immediate Postischemic Hypothermia on Chronic Neuronal Survival after Global Forebrain Ischemia in Rats

Potential Application of Intranasal Insulin Delivery for Treatment of Intracerebral Hemorrhage: A Review of The Literature

Insulin Growth Factor-1 Gene Transfer Enhances Neurovascular Remodeling and Improves Long-Term Stroke Outcome in Mice

Combinatorial intranasal delivery of bone marrow mesenchymal stem cells and insulin-like growth factor-1 improves neurovascularization and functional outcomes following focal cerebral ischemia in mice

Postischemic IGF-1 Gene Transfer Promotes Neurovascular Regeneration after Experimental Stroke

The dose-effectiveness of intranasal VEGF in treatment of experimental stroke.

Intranasal administration of basic flbroblast growth factor for a rat model of cerebral infarction: an experimental study

Method of Intra‐Arterial Administration in a transient MCAO Rat model to mimic the treatment of the human patient

Intranasal Insulin Treatment Attenuates Metabolic Distress and Early Brain Injury After Subarachnoid Hemorrhage in Mice

Intranasal Insulin Administration to Rats with Forebrain Ischemia and Reperfusion Injury Reduces Autophagy and Apoptosis Intensity in the Hippocampus and Frontal Cortex, a Possible Mechanism of Action

The Expression and Significance of Insulin-like Growth Factor-1 in Rats with Focal Cerebral Ischemia-reperfusion

Effect Of Remote Ischemic Postconditioning On An Intracerebral Hemorrhage Stroke Model In Rats

VEGF Promotes Angiogenesis and Functional Recovery in Stroke Rats.

Intranasal Administration of VEGF with Effect on Angiogenesis in Infarction Boundary Zones in Rats with Cerebral Ischemia